Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160029/S029

HeartStart OnSite Defibrillator (Model M5066A) and HeartStart Home Defibrillator (Model M5068A)

Philips Medical Systems, Inc. · Decision date Feb 2, 2026

FDA DECISIONP160029/S029

What did the FDA decide?

FDA records P160029/S029 as a supplement to PMA P160029, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 2, 2026.

FDA approval order statement

an update from the current manual manufacturing method to a semi-automated manufacturing method
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Feb 2, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P160029/S029
Regulatory pathway
PMA supplement
Product code
NSA
Decision code
OK30
Decision date
Feb 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Over-the-counter automated external defibrillator.

Product code
NSA
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P160029/S029 received

    Application receipt date recorded by FDA.

  2. P160029/S029 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P160029. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Philips Medical Systems, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
22100 Bothell-Everett Hwy., Bothell, WA, 98021

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records